- Видео 38
- Просмотров 4 504
i3 Health
Добавлен 29 июн 2011
i3 Health's mission is to enhance the proficiency of the multidisciplinary cancer care team by providing evidence-based, fair-balanced CME/CE-certified activities that address identified health care gaps and unmet educational needs.
Additional Advances in Immune-Related Adverse Events Research and Trials With Beth Sandy, MSN, CRNP
Click here to view the full activity and claim free NCPD credit! i3health.com/course-information/managing-immune-related-adverse-events-to-ensure-optimal-cancer-immunotherapy-outcomes-the-nurses-view
At last year’s Greater Los Angeles Oncology Nursing Society (GLAONS) Oncology Care Summit, i3 Health hosted a nursing continuing professional development (NCPD) symposium entitled Managing Immune-Related Adverse Events to Ensure Optimal Cancer Immunotherapy Outcomes (IRAEs): The Nurse’s View, chaired by Blanca Ledezma, MSN, NP, AOCNP®, Hematology/Oncology Nurse Practitioner at UCLA Health. With numerous advances in the immunotherapy space occurring since the symposium was held, Oncology Data A...
At last year’s Greater Los Angeles Oncology Nursing Society (GLAONS) Oncology Care Summit, i3 Health hosted a nursing continuing professional development (NCPD) symposium entitled Managing Immune-Related Adverse Events to Ensure Optimal Cancer Immunotherapy Outcomes (IRAEs): The Nurse’s View, chaired by Blanca Ledezma, MSN, NP, AOCNP®, Hematology/Oncology Nurse Practitioner at UCLA Health. With numerous advances in the immunotherapy space occurring since the symposium was held, Oncology Data A...
Просмотров: 44
Видео
Podcast: Implementing MCED Testing in Clinical Practice Through Case Studies - Module 3
Просмотров 1112 часов назад
To claim CME please visit this link: bit.ly/46W9Nhu STATEMENT OF NEED Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all can...
Podcast: Implementing MCED Testing: Optimizing Cancer Screening - Module 2
Просмотров 37День назад
To claim CME please visit this link: bit.ly/46W9Nhu STATEMENT OF NEED Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). Multicancer early detection (MCED) is an emerging form of blood-based testing t...
Podcast: Implementing MCED Testing: Optimizing Cancer Screening - Module 1
Просмотров 27День назад
To claim CME please visit this link: bit.ly/3AvL3kp STATEMENT OF NEED Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all can...
Implementing MCED Testing: Optimizing Cancer Screening - Module 3
Просмотров 2214 дней назад
To claim CME please visit this link: bit.ly/3SSR68M STATEMENT OF NEED Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all can...
Implementing MCED Testing: Optimizing Cancer Screening - Module 2
Просмотров 4414 дней назад
To claim CME please visit this link: bit.ly/3MbbONx STATEMENT OF NEED Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). Multicancer early detection (MCED) is an emerging form of blood-based testing t...
Implementing MCED Testing: Optimizing Cancer Screening - Module 1
Просмотров 5814 дней назад
To claim CME please visit this link: bit.ly/3Xe91s7 STATEMENT OF NEED Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all can...
Von Hippel-Lindau Disease: Free Online CME & NCPD
Просмотров 45Месяц назад
To claim CME/NCPD please visit this link: bit.ly/4c9mu9K STATEMENT OF NEED Von Hippel-Lindau disease (VHL) is an autosomal dominant disease in which germline pathogenic variants in the VHL gene predispose individuals to specific types of benign tumors, malignant tumors, and cysts in multiple organs, including clear cell renal cell carcinoma (RCC), renal cysts, central nervous system hemangiobla...
Additional Advances in Rett Syndrome Research and Clinical Trials With Timothy John Feyma, MD
Просмотров 38Месяц назад
Click here to view Dr. Feyma’s full CME/NCPD activity and claim credit: i3health.com/course-information/rett-syndrome Dr. Timothy John Feyma, Pediatric Neurologist at Gillette Children’s Hospital, is currently serving as chair of i3 Health’s CME/NCPD activity, Exploring Novel Treatments for Rett Syndrome. With new developments in the field occurring over recent months, Dr. Feyma sat down with u...
Getting Ahead of the ALS Curve Through Early Detection and Intervention: Module 1
Просмотров 652 месяца назад
To claim CME/NCPD visit this link: bit.ly/4eOeFcm 0.5 CME | 0.5 NCPD | MOC | ILNA STATEMENT OF NEED Amyotrophic lateral sclerosis (ALS) is a neurological disorder in which motor neurons deteriorate and result in muscle atrophy. As the disease progresses, affected individuals lose control of voluntary movements such as breathing, walking, talking, and chewing. Because treatments for slowing prog...
Practice-Changing Advances in the Management of Hemophilia
Просмотров 532 месяца назад
To claim CME/NCPD visit this link: bit.ly/3zjwiAr 0.75 CME | 0.75 NCPD | MOC | ILNA STATEMENT OF NEED Hemophilia is an inherited bleeding disorder in which the blood does not clot properly, causing affected individuals to experience spontaneous bleeding as well as bleeding after injuries or surgery. The 2 most common types are hemophilia A, caused by low levels of clotting factor VIII; and hemo...
A Webinar Sneak Peek: Von Hippel-Lindau Disease Treatment Advances With Eric Jonasch, MD
Просмотров 262 месяца назад
Join us on Wednesday, June 26 at 8:00 am EST or on Thursday, July 11 at 4:00 pm for this live webinar and earn free CME, NCPD, or NSGC CEU credit. Scan the QR code in the video to register for this webinar or visit i3health.com/course-information/comprehensive-management-of-von-hippel-lindau-disease-genetic-and-oncological-perspectives At this year’s American Society of Clinical Oncology (ASCO)...
Cold Agglutinin Disease: Answers to Frequently Asked Questions With Catherine Broome, MD
Просмотров 232 месяца назад
In this video, Dr. Catherine M. Broome, Professor of Medicine at Georgetown University Medical Center, answers questions asked by the audience during her CME/NCPD-approved activity with i3 Health, Putting the Freeze on Cold Agglutinin Disease (CAD). Dr. Broome shares insights into resources she recommends for patients with CAD, the role of thromboprophylaxis, treatment advances to expect within...
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | Free Online CME
Просмотров 1504 месяца назад
To claim CME/NCPD visit this link: bit.ly/4cTAB4S 1.5 CME | 1.5 NCPD | MOC | ILNA STATEMENT OF NEED Head and neck squamous cell carcinoma (HNSCC) represents a heterogeneous group of tumors originating in the mucosal epithelium of the oral cavity, pharynx, and larynx (Johnson et al, 2020). With an aggressive disease course, recurrence rates for HNSCC are high, and prognosis remains poor for adva...
Exploring AI for Educational Content Creation and Outcomes Assessment: Gregory Salinas, PhD, FACEHP
Просмотров 426 месяцев назад
Exploring AI for Educational Content Creation and Outcomes Assessment: Gregory Salinas, PhD, FACEHP
MRD Testing in Hematologic Malignancies | Free Online CME
Просмотров 306 месяцев назад
MRD Testing in Hematologic Malignancies | Free Online CME
Live or Virtual Fellows Meeting focusing Multiple Myeloma
Просмотров 436 месяцев назад
Live or Virtual Fellows Meeting focusing Multiple Myeloma
Early Diagnosis and Treatment of Alzheimer Disease | Free Online CME
Просмотров 737 месяцев назад
Early Diagnosis and Treatment of Alzheimer Disease | Free Online CME
Rare Disease Day: Acquired Thrombotic Thrombocytopenic Purpura
Просмотров 567 месяцев назад
Rare Disease Day: Acquired Thrombotic Thrombocytopenic Purpura
Rare Disease Day: Cold Agglutinin Disease
Просмотров 767 месяцев назад
Rare Disease Day: Cold Agglutinin Disease
Novel Treatments for Rett Syndrome | Free Online CME
Просмотров 538 месяцев назад
Novel Treatments for Rett Syndrome | Free Online CME
Managing Immune-Related Adverse Events | Free Online CME
Просмотров 26110 месяцев назад
Managing Immune-Related Adverse Events | Free Online CME
Cold Agglutinin Disease | Free Online CME
Просмотров 1 тыс.11 месяцев назад
Cold Agglutinin Disease | Free Online CME
National Immunization Awareness Month With Richa Thakur, MD, and Waqas Haque, MD
Просмотров 87Год назад
National Immunization Awareness Month With Richa Thakur, MD, and Waqas Haque, MD
Current Standards and New Directions in the Treatment of aTTP | Free Online CME
Просмотров 137Год назад
Current Standards and New Directions in the Treatment of aTTP | Free Online CME
Additional Advances in Multiple Myeloma Research and Clinical Trials With Shaji Kumar, MD
Просмотров 136Год назад
Additional Advances in Multiple Myeloma Research and Clinical Trials With Shaji Kumar, MD
World Cancer Research Day, an Interview with Dr. Thomas Abrams
Просмотров 542 года назад
World Cancer Research Day, an Interview with Dr. Thomas Abrams
Update on Immunotherapeutic Strategies for Advanced Merkel Cell Carcinoma
Просмотров 7033 года назад
Update on Immunotherapeutic Strategies for Advanced Merkel Cell Carcinoma